Liz Barrett is the President & Chief Executive Officer of UroGen, a clinical stage biopharmaceutical company focused on urological-oncology diseases.

Prior to joining UroGen, Ms. Barrett was the Chief Executive Officer of Oncology at Novartis, where she oversaw more than 10,000 associates in 85 countries. Ms. Barrett was also a member of the Executive Committee of Novartis.

Ms. Barrett was previously Global President of Oncology at Pfizer, Inc. While at Pfizer, Ms. Barrett held numerous leadership positions, including President of Global Innovative Pharma for Europe, President of the Specialty Care business unit for North America, and President of United States Oncology. Prior to Pfizer, she was Vice President and General Manager, Oncology business unit at Cephalon Inc. from 2006 to 2009, where she built the unit from scratch and launched Cephalon into Oncology. Ms. Barrett also worked at Johnson & Johnson across their consumer, diagnostics and biopharma sectors. Ms. Barrett started her career at Kraft Foods Group Inc. in 1984.

Ms. Barrett holds a Bachelor of Science from the University of Louisiana and a Master of Business Administration from Saint Joseph’s University.